IL1B and Parkinson disease: Also, in a mouse model of Parkinson's disease, MET reduced the numbers of microglia and proinflammatory cytokines TNF‐α, IL‐1β, IL‐6, and iNOS (Ismaiel et al., 2016; Lu et al., 2016).